Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Australia Alopecia (Hair Loss) Treatment Market Forecast 2021-2026

Published by Inkwood Research Product code 1018676
Published Content info 97 Pages
Delivery time: 2-3 business days
Price
Back to Top
Australia Alopecia (Hair Loss) Treatment Market Forecast 2021-2026
Published: July 19, 2021 Content info: 97 Pages
Description

KEY FINDINGS

The Australia alopecia (hair loss) treatment market is set to record a CAGR of 6.48% during the forecast period, 2021-2026. The increasing internet penetration, unhealthy dietary habits, and sedentary lifestyle propel market growth.

MARKET INSIGHTS

In Australia, as per the Australian Institute of Health and Welfare, 68% of men aged 18 and above are obese, attributed to a high cholesterol diet, which causes hair loss. Also, stress levels are majorly adding to the increasing alopecia cases in females and males. Moreover, organizations like Australia Alpoecia Areata Foundation Inc (AAAF) support people suffering from alopecia through their work and spread disease awareness.

Furthermore, the market growth was influenced by the impact of the pandemic, especially on the proper functioning of the hair care industry in Australia. People prioritized hygiene that boosted the shampoo product demands. In addition, the closure of salons due to lockdown and associated restrictions resulted in companies innovating at-home hair dyes for consumers.

Also, with the increasing number of people gaining awareness about the benefits of organic and natural products, there is a huge demand for natural ingredients. As a result, companies are launching products with nature-inspired ingredients like premium botanical and plant-inspired ingredients. Such factors contribute to market growth in Australia.

COMPETITIVE INSIGHTS

Some of the eminent companies in the market include: Teva Pharmaceutical Industries Ltd, Cellmid, Transitions Hair Pvt Ltd, Cipla Limited, Taisho Pharmaceutical Co Ltd, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 38975

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. COUNTRY SNAPSHOT
  • 2.3. COUNTRY ANALYSIS
  • 2.4. KEY GROWTH ENABLERS
  • 2.5. KEY CHALLENGES

3. KEY ANALYTICS

  • 3.1. IMPACT OF COVID-19 ON AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET
  • 3.2. KEY MARKET TRENDS
  • 3.3. PORTER'S FIVE FORCES ANALYSIS
    • 3.3.1. BUYERS POWER
    • 3.3.2. SUPPLIERS POWER
    • 3.3.3. SUBSTITUTION
    • 3.3.4. NEW ENTRANTS
    • 3.3.5. INDUSTRY RIVALRY
  • 3.4. OPPORTUNITY MATRIX
  • 3.5. VENDOR LANDSCAPE

4. MARKET BY GENDER

  • 4.1. FEMALE
  • 4.2. MALE

5. MARKET BY INDICATIONS

  • 5.1. ANDROGENIC ALOPECIA
  • 5.2. ALOPECIA AREATA
  • 5.3. ALOPECIA TOTALIS
  • 5.4. OTHER INDICATIONS

6. MARKET BY DISTRIBUTION CHANNELS

  • 6.1. DRUG STORES & RETAIL PHARMACIES
  • 6.2. HOSPITAL PHARMACIES
  • 6.3. ONLINE PHARMACIES

7. MARKET BY TREATMENT

  • 7.1. TOPICAL
    • 7.1.1. MINOXIDIL
    • 7.1.2. SHAMPOOS
  • 7.2. ORAL
    • 7.2.1. FINASTERIDE
    • 7.2.2. OTHER ORAL HAIR LOSS TREATMENT
  • 7.3. OTHER TREATMENT TYPES

8. COMPETITIVE LANDSCAPE

  • 8.1. KEY STRATEGIC DEVELOPMENTS
    • 8.1.1. MERGERS & ACQUISITIONS
    • 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 8.1.3. PARTNERSHIPS & AGREEMENTS
    • 8.1.4. BUSINESS EXPANSIONS/DIVESTITURES
  • 8.2. COMPANY PROFILES
    • 8.2.1. CELLMID
    • 8.2.2. CIPLA LIMITED
    • 8.2.3. TAISHO PHARMACEUTICAL CO LTD
    • 8.2.4. TEVA PHARMACEUTICAL INDUSTRIES LTD
    • 8.2.5. TRANSITIONS HAIR PVT LTD

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT
  • TABLE 2: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 4: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY INDICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY INDICATIONS, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 6: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DISTRIBUTION CHANNELS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DISTRIBUTION CHANNELS, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 8: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TREATMENT, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 10: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 12: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 14: LIST OF MERGERS & ACQUISITIONS
  • TABLE 15: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 16: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 17: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY GENDER, IN 2020
  • FIGURE 6: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY FEMALE, 2021-2026 (IN $ MILLION)
  • FIGURE 7: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY MALE, 2021-2026 (IN $ MILLION)
  • FIGURE 8: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY INDICATIONS, IN 2020
  • FIGURE 9: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ANDROGENIC ALOPECIA, 2021-2026 (IN $ MILLION)
  • FIGURE 10: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ALOPECIA AREATA, 2021-2026 (IN $ MILLION)
  • FIGURE 11: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ALOPECIA TOTALIS, 2021-2026 (IN $ MILLION)
  • FIGURE 12: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER INDICATIONS, 2021-2026 (IN $ MILLION)
  • FIGURE 13: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNELS, IN 2020
  • FIGURE 14: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DRUG STORES & RETAIL PHARMACIES, 2021-2026 (IN $ MILLION)
  • FIGURE 15: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY HOSPITAL PHARMACIES, 2021-2026 (IN $ MILLION)
  • FIGURE 16: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ONLINE PHARMACIES, 2021-2026 (IN $ MILLION)
  • FIGURE 17: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY TREATMENT, IN 2020
  • FIGURE 18: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL, 2021-2026 (IN $ MILLION)
  • FIGURE 19: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY TOPICAL HAIR LOSS TREATMENT, IN 2020
  • FIGURE 20: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY MINOXIDIL, 2021-2026 (IN $ MILLION)
  • FIGURE 21: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY SHAMPOOS, 2021-2026 (IN $ MILLION)
  • FIGURE 22: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL, 2021-2026 (IN $ MILLION)
  • FIGURE 23: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY ORAL HAIR LOSS TREATMENT, IN 2020
  • FIGURE 24: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY FINASTERIDE, 2021-2026 (IN $ MILLION)
  • FIGURE 25: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER ORAL HAIR LOSS TREATMENT, 2021-2026 (IN $ MILLION)
  • FIGURE 26: AUSTRALIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER TREATMENT TYPES, 2021-2026 (IN $ MILLION)
Back to Top